hepat
c
viru
hcv
infect
million
peopl
worldwid
repres
heavi
burden
global
health
highest
preval
rate
found
africa
eastern
acut
hcv
infect
asymptomat
infect
individu
viru
persist
progress
chronic
liver
diseas
includ
fibrosi
steatosi
cirrhosi
hepatocellular
furthermor
hcv
major
caus
type
mix
cryoglobulinemia
occur
use
hcv
genotyp
isol
japanes
fulmin
genomebas
cell
culturederiv
infecti
hcv
hcvcc
zhong
et
demonstr
hcv
cell
coevolv
vitro
chronic
persist
infect
involv
select
viral
mutant
increas
infect
cell
resist
viral
entri
andor
rna
replic
coevolut
process
hcv
exhibit
multifacet
interact
host
cell
cellular
stress
respons
subsequ
affect
viru
replic
instanc
infect
hcvcc
express
japanes
fulmin
genom
shown
trigger
cytopath
effect
endoplasm
reticulum
er
stress
unfold
protein
respons
upr
autophagi
innat
immun
competit
viru
host
cell
viral
infect
often
trigger
firstlin
host
defens
product
type
interferon
ifn
broadli
act
antivir
cytokin
inflammatori
cytokin
cytokin
confer
antivir
state
host
cell
therebi
interf
viral
abil
enhanc
immun
respons
viru
clearanc
inhibit
viral
replic
ifnbas
therapi
use
treat
hcvinfect
patient
two
guard
viral
infect
host
cell
develop
multipl
restrict
strategi
limit
viral
infect
express
mani
restrict
factor
subject
transcript
regul
upon
infect
virus
hcv
viral
rna
first
sens
cellular
pattern
recognit
receptor
prr
prrmediat
recruit
adaptor
protein
activ
downstream
signal
lead
ifn
bind
receptor
ifnar
complex
present
cell
surfac
ifn
trigger
janu
kinas
jak
signal
transduc
activ
transcript
stat
pathway
drive
synthesi
ifnstimul
gene
isg
block
viru
replic
differ
phase
viru
replic
isg
usual
synthes
basal
state
induc
express
mediat
antivir
effector
function
ifn
upon
viral
infect
ifn
treatment
respons
virus
develop
elabor
strategi
escap
ifn
antivir
system
block
express
antivir
function
therefor
host
hcv
maintain
homeostat
state
allow
tightli
restrict
viral
replic
without
kill
recent
studi
genomewid
sirna
screen
also
ad
new
candid
grow
list
antihcv
isg
find
highlight
complex
pleiotrop
role
ifn
induc
isg
modul
innat
immun
viru
replic
nevertheless
complet
spectrum
isg
function
suppress
hcv
replic
yet
review
focu
molecular
aspect
type
ifn
system
effector
mechan
modul
hcv
replic
first
briefli
discuss
signal
trigger
retino
acidinduc
gene
receptor
rlr
tolllik
receptor
tlr
lead
type
ifn
synthesi
ifnmedi
signal
pathway
activ
result
express
varieti
effector
isg
also
summar
strategi
hcv
use
escap
ifn
antivir
surveil
addit
highlight
current
known
regard
pivot
isg
viral
infect
emphasi
antihcv
activ
emerg
isg
identifi
recent
genomewid
sirna
screen
relat
antihcv
activ
final
discuss
potenti
function
sever
critic
cellular
factor
highmobl
group
box
immunityrel
gtpase
famili
irgm
cellular
pathway
upr
autophagi
hcv
infect
although
cellular
determin
stimul
ifn
factor
critic
control
host
immun
respons
therefor
determin
may
also
play
crucial
role
modifi
hcv
replic
review
provid
perspect
better
understand
antihcv
mechan
ifn
isg
sever
critic
cellular
determin
known
contribut
regul
innat
immun
gather
inform
provid
clearer
pictur
specif
function
complex
ifn
system
effector
mechan
control
hcv
infect
also
help
identifi
novel
cellular
target
efficaci
therapeut
strategi
develop
clinic
identif
new
isg
also
help
optim
current
ifnbas
therapi
provid
basi
accur
predict
ifn
treatment
outcom
hcv
envelop
positivesens
singlestrand
rna
viru
classifi
within
genu
hepaciviru
flavivirida
current
hcv
isol
classifi
seven
major
genotyp
ie
genotyp
array
hcv
genotyp
differ
genom
wherea
subtyp
within
genotyp
differ
least
genotyp
preval
follow
genotyp
genotyp
cumul
approxim
genotyp
less
differ
genotyp
exhibit
distinct
geograph
distribut
genotyp
predomin
america
europ
genotyp
japan
genotyp
asia
genotyp
africa
middl
east
genotyp
southeast
hcv
transmit
via
blood
transfus
intraven
drug
abus
unsaf
therapeut
inject
liver
transplant
risk
combin
pegyl
ribavirin
standard
therapi
hcv
infect
howev
treatment
associ
side
effect
efficaci
regimen
vari
among
genotyp
limit
success
rate
compar
genotyp
infect
genotyp
result
sever
liver
diseas
low
respons
ifn
therapi
seventyon
percent
patient
genotyp
infect
respond
ifn
therapi
wherea
genotyp
genotyp
show
patient
infect
genotyp
gener
show
higher
sustain
virolog
respons
ifn
therapi
genotyp
wherea
genotyp
patient
show
lower
sustain
virolog
respons
compar
genotyp
heterogen
hcv
genotyp
also
translat
differ
manifest
liver
exampl
hepat
steatosi
common
patient
infect
genotyp
attribut
core
recent
use
activ
directact
antivir
molecul
block
hcv
infect
led
substanti
improv
sustain
virolog
respons
rate
genotyp
patient
howev
use
drug
may
allow
select
resist
variant
directact
antivir
monotherapi
adopt
high
relaps
rate
occur
directact
antivir
treatment
approxim
hcv
genom
contain
singl
open
read
frame
flank
untransl
region
utr
end
figur
intern
ribosom
entri
site
ire
locat
direct
capindepend
translat
wherea
contain
sequenc
critic
viral
replic
posit
nucleotid
hcv
genom
contain
poli
uuc
puuc
tract
locat
nucleotid
posit
identifi
hcv
pathogenassoci
molecular
pattern
pamp
trigger
rlrmediat
type
ifn
product
figur
translat
hcv
genom
rna
produc
singl
polyprotein
approxim
amino
acid
process
cellular
viral
proteas
yield
structur
protein
core
nonstructur
ns
protein
figur
ns
protein
particip
differ
phase
viral
replic
cycl
figur
exampl
protein
import
rna
jone
et
show
requir
entri
assembl
viru
research
also
report
involv
virion
assembl
product
hepatocyt
primari
target
cell
hcv
replic
upon
infect
viru
particl
circul
blood
biochem
resembl
lowdens
lipoprotein
rich
apolipoprotein
apo
e
first
apolipoproteinassoci
lipovir
particl
lvp
attach
glycosaminoglycan
lowdens
lipoprotein
receptor
interact
cluster
differenti
scaveng
receptor
class
b
number
figur
lvp
subsequ
transloc
tight
junction
hepatocyt
lvp
bind
tight
junction
protein
occludin
follow
intern
hcv
particl
via
phdepend
endocytosi
occur
plasma
membran
figur
addit
receptor
cell
surfac
molecul
epiderm
growth
factor
receptor
ephrin
receptor
niemannpick
cholesterol
uptak
receptor
also
essenti
viru
subsequ
intern
acid
ph
endosom
trigger
fusion
viral
envelop
endosom
membran
allow
releas
viral
genom
cytoplasm
figur
hcv
genom
translat
occur
rough
er
hcv
rna
replic
erderiv
erassoci
lipidrich
environ
term
membran
web
figur
hcv
ns
protein
except
involv
viral
rna
replic
ns
protein
coloc
replic
viral
rna
light
densiti
detergentresist
cytoplasm
membran
structur
term
lipid
lipid
droplet
ld
compris
neutral
lipid
core
singl
phospholipid
layer
serv
energi
storag
site
reservoir
neutral
lipid
adipos
tissu
ld
indispens
viral
rna
replic
infecti
viru
initi
stage
viru
assembl
hcv
core
protein
interact
viral
replic
complex
also
direct
ld
coredepend
manner
allow
encapsid
viral
rna
core
protein
assembl
nucleocapsid
figur
addit
interact
actin
tubulin
microtubul
network
mediat
transloc
hcv
replic
complex
late
stage
viru
assembl
occur
lumen
er
involv
acquisit
lipid
envelop
embed
envelop
format
nascent
virion
figur
nascent
viru
particl
associ
apob
apo
lowdens
lipoprotein
lipid
form
final
lvp
releas
cell
lowdens
lipoprotein
secret
pathway
endosom
secretori
pathway
figur
similar
ns
protein
play
numer
crucial
function
virion
assembl
integr
oligomer
membran
protein
consist
amino
acid
group
famili
viroporin
form
membran
pore
function
ion
channel
modul
membran
permeabl
facilit
viru
entri
promot
viru
uncoat
enhanc
assembl
conduct
ion
across
membran
channel
activ
abrog
drug
amantadin
iminosugar
matur
egress
ion
channel
activ
maintain
ph
gradient
within
secretori
pathway
therebi
stabil
hcv
addit
shown
necessari
capsid
assembl
envelop
mutat
result
accumul
incomplet
assembl
capsid
unabl
encapsid
viral
ifn
system
constitut
firstlin
defens
mechan
viral
infect
base
antivir
properti
ifn
group
three
class
type
ii
iii
human
type
ifn
compris
larg
group
molecul
encod
multipl
gene
mainli
gene
combat
virus
directli
inhibit
viru
replic
indirectli
induc
innat
immun
cell
type
elicit
type
ifn
respons
activ
tlr
rlr
type
ii
ifn
contain
one
member
unlik
type
ifn
elicit
direct
respons
viral
infect
secret
natur
killer
cell
mitogen
activ
exert
potent
antihcv
activ
vitro
mediat
antivir
tcell
respons
also
report
inhibit
hcv
infect
downregul
type
iii
ifn
consist
three
member
term
type
ifn
viral
infect
also
directli
activ
type
iii
ifn
howev
antivir
properti
mechan
action
type
iii
ifn
remain
unknown
type
iii
ifn
secret
mani
cell
type
receptor
show
limit
tissu
hcv
infect
result
type
iii
ifn
induct
predominantli
human
liver
despit
modul
pathway
induct
type
iii
type
ifn
two
system
upregul
distinct
subset
isg
differ
kinet
hcv
infect
cell
produc
type
ifn
counteract
viral
infect
modul
viral
replic
activ
natur
killer
cell
dendrit
cell
kupffer
recognit
pamp
prr
includ
tlr
rlr
trigger
ifn
synthesi
ifnmedi
cascad
signal
pathway
lead
product
type
ifn
wide
rang
isg
mediat
ifn
antivir
activ
figur
upon
viru
infect
tlr
rlr
oper
differ
signal
pathway
depend
natur
viral
signal
tlr
express
local
intracellular
compart
similar
endosom
cell
unlik
rlr
tlr
potenti
detect
viral
doublestrand
rna
dsrna
releas
cell
extracellular
milieu
figur
three
type
tlr
ie
involv
recognit
viru
infect
detect
dsrna
form
replic
positivestrand
rna
virus
wherea
recogn
urinerich
ribonucleotid
region
rna
sens
dna
pamp
motif
encod
cpg
upon
bind
pamp
dimer
initi
bind
cytosol
receptor
adaptor
protein
receptor
domaincontain
adaptor
induc
trif
result
associ
trif
figur
interact
lead
recruit
tumor
necrosi
factor
tnf
receptorassoci
factor
traf
traf
famili
member
nuclear
factor
kappalightchainenhanc
activ
b
cell
activatorbind
kinas
result
phosphoryl
activ
ifn
regulatori
factor
irf
inhibitor
kappa
b
kinaserel
kinas
ikk
phosphoryl
protein
dimer
transloc
nucleu
form
enhanceosom
complex
transcript
factor
therebi
induc
express
target
gene
moreov
bind
viral
dsrna
tlr
also
activ
activ
proinflammatori
cytokin
synthesi
interact
trif
receptorinteract
bind
myeloid
differenti
proinflammatori
respons
activ
receptorassoci
kinas
irak
follow
activ
turn
activ
phosphoryl
polyubiquitin
proteasom
degrad
associ
inhibitor
migrat
nucleu
result
ifn
product
figur
rlr
receptor
consist
rigi
melanoma
differentiationassoci
protein
laboratori
genet
rigi
recogn
hcv
replic
intermedi
dsrna
within
hour
infect
trigger
downstream
signal
viral
protein
extens
synthes
figur
rigi
sens
short
nonself
dsrna
wherea
rna
lack
picornavirus
recogn
rigi
contain
two
ntermin
caspas
activ
recruit
domain
card
recognit
dsrna
rigi
depend
upon
atpdriven
translocas
activ
card
helicas
bind
dsrna
induc
conform
chang
rigi
facilit
oligomer
transloc
cytosol
mitochondri
mitochondria
rigi
engag
via
tandem
card
card
downstream
effector
mitochondria
antivir
signal
protein
mav
also
term
promot
virusinduc
signal
adaptor
card
adaptor
induc
figur
chaperon
protein
ring
finger
domaincontain
ubiquitin
ub
ligas
tripl
motifcontain
protein
trim
also
particip
process
mediat
ubiquitin
rigi
posit
import
mav
bind
ifn
interact
rigi
mav
promot
format
signal
complex
mitochondri
surfac
recruit
activ
downstream
classic
ikk
complex
two
nonclass
ikkrel
kinas
activ
lead
phosphoryl
dimer
nuclear
transloc
transcript
factor
figur
mitogenactiv
protein
kinaseextracellular
signalregul
kinas
erk
kinas
also
recruit
mav
activ
canon
induc
gene
transcript
via
phosphoryl
polyubiquitin
proteasom
degrad
therebi
result
releas
nuclear
migrat
activ
involv
interact
bcell
lymphomaleukemia
protein
activ
transloc
nucleu
form
enhanceosom
therebi
stimul
express
ifn
inflammatori
cytokin
help
cellular
factor
activ
transcript
protein
secret
ifn
bind
ifnar
cell
surfac
trigger
signal
pathway
figur
follow
ifnar
receptor
bind
tyrosin
activ
phosphoryl
form
heterodim
subsequ
recruit
form
transcript
factor
ifnstimul
gene
factor
transloc
nucleu
bind
ifnsensit
respons
element
isr
transactiv
express
variou
isg
oligoadenylatesynthetas
oligoadenyl
depend
latent
endoribonucleas
rnase
l
dsrnadepend
protein
kinas
r
pkr
figur
hcv
core
protein
involv
format
viral
nucleocapsid
modul
mani
cellular
function
includ
transcript
signal
transduct
express
fulllength
hcv
genom
core
protein
downregul
ifn
signal
depress
tyrosin
phosphoryl
block
heterodimer
inhibit
ifn
signal
transduct
isg
express
figur
addit
express
core
protein
induc
synthesi
suppressor
cytokin
signal
import
repressor
pathway
due
abil
inhibit
phosphoryl
figur
thu
hcv
core
protein
induc
suppress
ifnmedi
isg
express
upregul
chronic
hcvinfect
patient
ifn
nonrespond
compar
core
protein
express
also
demonstr
inhibit
synthesi
transcript
repress
sever
isg
mani
virus
use
molecular
mimicri
import
immun
evas
strategi
promot
viru
surviv
virus
express
protein
structur
similar
host
defens
protein
viral
protein
act
immun
hcv
employ
molecular
mimicri
strategi
resist
type
ifn
envelop
compris
acid
sequenc
ident
eukaryot
initi
factor
domain
oper
prevent
pkrdepend
phosphoryl
repress
protein
synthesi
thu
possess
abil
resist
type
ifn
treatment
figur
hcv
proteas
respons
matur
ns
protein
viral
rna
replic
virion
morphogenesi
also
import
suppress
host
antivir
complex
anchor
intracellular
membran
transmembran
domain
amphipath
domain
facilit
cleavag
two
cellular
target
mav
trif
act
key
player
type
ifn
product
figur
mav
essenti
antivir
signal
protein
rlr
system
therefor
ideal
target
viral
immun
evas
serv
primari
membran
subcellular
target
subunit
escort
bind
mav
cleav
mav
result
disloc
ntermin
portion
mav
mitochondria
suppress
ifn
product
figur
hydrophob
amino
acid
stretch
amphipath
also
requir
control
rigi
cleavag
mav
reduct
ifn
level
observ
chronic
hcvinfect
thu
cleavag
mav
rigi
signal
impair
ifn
addit
proteas
also
cleav
trif
adaptor
protein
link
kinas
respons
activ
figur
cleavag
trif
interfer
poli
c
activ
tlr
signal
activ
therebi
limit
express
multipl
host
defens
gene
enhanc
hcv
stimul
interferon
gene
sting
also
known
mediat
activ
mita
protein
mainli
local
respons
dsdna
transfect
dna
viru
infect
sting
play
crucial
role
activ
transcript
pathway
essenti
effect
innat
immun
upon
dsdna
stimul
sting
polymer
transloc
er
cytoplasm
punctat
structur
sting
polym
provid
platform
connect
phosphoryl
therebi
trigger
downstream
viral
infect
yellow
fever
viru
yfv
block
induct
ifn
product
pathway
interact
dengu
viru
denv
act
proteas
cleav
sting
therebi
shut
ifn
hcv
infect
interact
sequest
sting
er
inhibit
associ
sting
tbk
suppress
ifn
signal
figur
therefor
target
sting
inhibit
innat
immun
might
benefici
viru
surviv
matur
hcv
present
two
phosphoprotein
hypophosphoryl
hyperphosphoryl
phosphoryl
occur
multipl
serin
residu
serin
upstream
ifn
sensit
determin
region
isdr
span
residu
base
genotyp
hcvj
strain
serin
residu
import
function
locat
signific
remain
unclear
howev
mainten
two
form
specif
ratio
critic
hcv
function
pleiotrop
protein
modul
host
environ
favor
viru
replic
addit
bind
major
adaptor
molecul
tlr
pathway
inhibit
recruit
attenu
tlr
signal
impair
cytokin
sequenc
within
isdr
span
residu
shown
respons
interact
death
domain
macrophag
pkr
ifninduc
gene
product
activ
bind
dsrna
commonli
produc
viral
replic
rescu
hcv
replic
ifntreat
cell
inhibit
ifn
antivir
activ
bind
pkr
block
pkr
autophosphoryl
express
suffici
rescu
replic
ifnsensit
interact
pkr
requir
isdr
overlap
broader
pkrbind
region
residu
result
inhibit
pkr
activ
resist
ifn
hcvexpress
consist
mechan
mutat
delet
isdr
correl
sensit
antivir
moreov
metaanalysi
longterm
followup
support
associ
isdr
region
outcom
ifn
therapi
region
encompass
genet
flexibl
domain
allow
mutat
occur
key
site
adapt
ifn
therapi
influenc
fit
hcv
rna
contrast
studi
suggest
inhibitori
effect
ifn
may
independ
pkr
increas
express
also
known
chemokin
upregul
promot
turn
inhibit
ifn
antivir
activ
facilit
viru
cell
cultur
model
cell
associ
chronic
hcv
infect
remov
mitig
hcv
importantli
serum
level
elev
chronic
hepat
c
patient
compar
control
individu
higher
ifn
nonrespond
rel
observ
suggest
express
increas
product
somehow
perturb
ifn
antivir
pathway
moreov
imped
l
system
inhibit
ifn
l
antivir
pathway
present
virtual
everi
pathway
involv
activ
latent
endoribonucleas
degrad
hcv
mrna
dsrna
structur
physic
bind
amino
acid
residu
singl
point
mutat
amino
acid
affect
bind
antivir
activ
l
thu
inhibit
ifn
antivir
activ
isdrindepend
manner
moreov
ifnresist
strain
genotyp
fewer
rnase
l
recognit
site
genom
ifnsensit
strain
genotyp
provid
mean
ifnresist
strain
escap
nucleotyl
apoptosi
also
play
key
role
host
defens
system
restrict
viral
spread
persist
block
apoptosi
could
critic
establish
lifelong
persist
host
organ
shown
block
activ
caspas
inhibit
proteolyt
cleavag
death
substrat
poli
adpribos
polymeras
adenoviru
infect
mice
downregul
upregul
express
tbox
transcript
factor
transact
cellspecif
transcript
factor
respect
result
lower
express
delay
viru
furthermor
stabl
express
human
hepatoma
cell
line
decreas
sensit
apoptosi
activ
inhibit
thu
protect
cell
apoptot
death
hcv
protein
express
induc
er
stress
respons
lead
calcium
releas
er
turn
activ
cyclic
amp
respons
elementbind
protein
bind
cyclic
amp
respons
element
promot
protein
phosphatas
result
upregul
express
essenti
cell
type
serinethreonin
phosphatas
involv
multipl
cellular
process
cell
cycl
signal
transduct
stress
increas
express
observ
cell
line
induc
overexpress
hcv
protein
liver
extract
hcv
transgen
mice
liver
biopsi
patient
chronic
hepat
duong
et
show
upregul
hcv
inhibit
enzymat
activ
protein
arginin
methyltransferas
lead
decreas
methyl
hypomethyl
prone
bind
protein
inhibitor
activ
inhibit
dimer
result
impair
nuclear
transloc
nucleu
bind
isr
isg
thu
hcvinduc
activ
disrupt
antivir
state
lead
hcv
evas
innat
immun
author
also
show
methyl
hcv
arginin
result
inhibit
helicas
therefor
hcvmediat
upregul
enhanc
helicas
activ
inhibit
enzymat
activ
turn
facilit
viru
rigi
encod
gene
belong
dexdh
box
rna
helicas
ddx
famili
key
player
defens
invas
mani
rna
rigi
sens
intracellular
viral
compon
initi
antivir
respons
stimul
ifn
product
tabl
turn
ifn
activ
transcript
rigi
henc
form
posit
feedback
loop
amplifi
antivir
studi
shown
rigi
essenti
elicit
immun
respons
vesicular
stomat
viru
vsv
sendai
viru
newcastl
diseas
viru
ndv
hepat
c
knockout
rigi
gene
mous
embryon
fibroblast
sever
limit
type
ifn
product
isg
activ
therebi
potenti
viral
replic
convers
overexpress
rigi
restrict
viral
addit
upregul
rigi
gene
express
observ
ifntreat
human
dendrit
cell
suggest
rigi
serv
rigi
contain
two
tandem
card
ntermin
region
repressor
domain
ctermin
region
card
respons
downstream
signal
activ
type
ifn
recognit
nonself
rna
wherea
repressor
domain
essenti
autoregul
recognit
viral
without
viral
stimul
card
interact
helicas
domain
place
rigi
autoinhibitori
state
disabl
signal
upon
bind
viral
rna
rigi
undergo
conform
chang
expos
card
allow
rigi
rigi
ubiquitin
two
differ
ligas
ring
finger
protein
ubiquitin
rigi
lysin
mediat
antivir
respons
wherea
ubiquitin
ring
finger
protein
regul
degrad
rigi
proteosom
therebi
downregul
rigimedi
ubiquitin
induc
rigi
form
tetram
promot
card
rigi
engag
card
mav
result
accumul
mav
mitochondri
membran
activ
ikk
turn
activ
transcript
promot
ifn
moreov
ubiquitin
also
prevent
card
interact
helicas
domain
reinstat
autoinhibitori
ubiquitin
lysin
crucial
rigi
function
mutat
residu
render
rigi
unabl
bind
mav
thu
abrog
downstream
also
dexdh
box
helicas
whose
function
remain
slightli
resembl
yeast
ski
protein
cofactor
rna
exosom
requir
control
host
rna
human
homolog
yeast
ski
rna
exosom
exhibit
antivir
activ
monkey
leukemia
viru
sindbi
viru
sinv
express
upregul
infect
measl
viru
mev
mrna
level
robustli
upregul
human
fetal
liver
cell
within
h
hcv
infect
provid
mean
initi
antivir
unlik
rigi
contain
card
interact
viral
infect
induc
bind
rigi
well
laboratori
genet
promot
bind
rigi
essenti
type
ifn
express
dna
viru
infect
induc
suppress
viral
replic
rlrdepend
manner
tabl
knockdown
reduc
express
type
ifn
hcv
hiv
yfv
first
identifi
transcript
activ
gene
unstimul
cell
express
low
level
howev
express
increas
induct
viral
nevertheless
precis
pathway
lead
activ
viru
infect
remain
elus
activ
may
proceed
pkrdepend
pathway
viru
infect
pkr
indirectli
phosphoryl
activ
dnabind
properti
thu
activ
regul
promot
function
promot
act
modul
mani
isg
bind
isr
promot
region
therebi
regul
viral
replic
tabl
control
ifn
antivir
respons
affect
set
isg
cooper
regul
cellular
antivir
gene
hcv
infect
increas
level
may
affect
irf
pathway
isg
express
therebi
lead
reduct
viral
overexpress
induc
antivir
state
affect
variou
virus
includ
ndv
vsv
express
level
reduc
cell
harbor
hcv
subgenom
replicon
sgr
wherea
overexpress
cell
increas
isr
activ
attenu
hcv
addit
hcv
infect
mediat
express
thu
affect
intracellular
level
hcv
howev
hcv
may
evad
antihcv
effect
coremedi
suppress
essenti
transcript
factor
induct
isg
element
ifn
respons
either
innat
adapt
immun
regul
constitut
express
certain
cell
macrophag
plasmacytoid
dendrit
cell
prime
cell
rapid
ifn
infect
bind
receptor
activ
pathway
result
phosphoryl
form
heterodim
transloc
nucleu
heterodim
bind
irf
element
promot
region
gene
lead
enhanc
express
subtyp
divers
rang
isg
tabl
turn
event
increas
abund
rigi
viral
pamp
signal
compon
wherea
sustain
signal
serv
amplifi
ifn
moreov
induc
express
isg
without
activ
ifn
thu
transcript
cascad
serv
intrins
antivir
mechan
allow
rapid
isg
express
ifn
product
play
import
role
elimin
hcv
infect
sirna
knockdown
decreas
product
increas
hcv
mice
lack
show
rapidli
lethal
infect
west
nile
viru
wnv
high
viru
defici
repress
induct
accumul
thu
favor
wnv
although
hcv
seem
suppress
basal
express
stimul
activ
suppress
hcv
observ
suggest
hcv
may
partial
inhibit
activ
hcvexpress
pkr
also
known
serinethreonin
kinas
phosphoryl
respons
viru
infect
ifninduc
kinas
two
distinct
activ
autophosphoryl
result
activ
phosphoryl
inactiv
phosphoryl
event
pkr
mediat
inhibit
translat
initi
cellular
viral
well
document
antihcv
activ
pkr
occur
translat
control
tabl
howev
virus
evolv
elabor
strategi
counteract
detriment
effect
pkr
hcv
ire
activ
shown
resist
pkr
activ
cell
harbor
hcv
sgr
hcv
infect
model
tabl
mechanist
virus
may
use
protein
imped
dsrnadepend
pathway
variou
way
sequest
dsrna
inhibit
pkr
activ
produc
pkr
pseudosubstr
activ
antagonist
phosphatas
degrad
indic
hcv
employ
antagon
pkr
function
result
resist
ifn
blockad
pkrmediat
inhibit
viral
protein
synthesi
tabl
analog
alphavirus
sinv
semliki
forest
hcv
activ
pkr
phosphoryl
enhanc
viral
protein
translat
tabl
compar
previous
studi
dsrna
domain
iiiiv
hcv
ire
shown
bind
ntermin
dsrnabind
domain
pkr
lead
increas
pkr
autophosphoryl
addit
capdepend
hcv
iresmedi
translat
inhibit
pkr
result
indic
escap
deleteri
effect
pkr
activ
hcv
employ
structur
ire
direct
protein
translat
karamichali
et
demonstr
activ
pkr
silenc
pkr
upregul
downregul
hcv
ire
activ
tabl
author
show
inhibitori
effect
iresdepend
translat
occur
pkr
contrast
hcv
translat
viral
protein
via
bacteriallik
pathway
use
analog
bacteri
instead
gtpaseactiv
protein
initi
factor
tabl
use
translat
initi
provid
altern
tactic
hcv
translat
inactiv
phosphoryl
stress
condit
mani
line
evid
reveal
hcvmediat
phosphoryl
activ
pkr
turn
inhibit
downstream
target
attenu
express
host
cellular
protein
includ
isg
without
inhibitori
effect
viral
iresmedi
viral
protein
translat
tabl
pkr
knockdown
hcvinfect
cell
restor
isg
express
enhanc
antivir
effect
result
demonstr
hcv
escap
ifn
antivir
activ
promot
phosphoryl
pkr
inhibit
product
antivir
isg
protein
thu
provid
interest
pathway
viru
evad
ifn
antivir
respons
furthermor
accumul
evid
reveal
pkr
particip
format
stress
granul
sg
sg
larg
dynam
structur
nm
size
form
cytoplasm
cell
undergo
extracellular
stress
includ
viral
sg
format
import
posttranscript
regul
gene
sg
contain
stall
translat
preiniti
complex
includ
cellular
mrna
translat
initi
factor
small
subunit
ribosom
mani
cellular
rna
bind
protein
tcellrestrict
intracellular
antigen
homolog
protein
tiar
domain
bind
protein
involv
regul
mrna
mani
virus
includ
hcv
modul
sg
assembl
coopt
sg
promot
protein
hcv
induc
sg
format
via
phosphoryl
tabl
consist
notion
upregul
regulatori
subunit
protein
phosphatas
dephosphoryl
growth
arrest
dna
damageinduc
protein
inhibit
sg
result
indic
import
phosphoryl
hcvinduc
sg
format
moreov
garaigorta
et
demonstr
hcvinduc
sg
format
ifn
pkrdepend
invers
correl
induct
isg
protein
myxoviru
resist
gene
mxa
ublik
ubl
specif
proteas
hcvinfect
cell
without
affect
mrna
level
isg
furthermor
sg
protein
tiar
shown
play
critic
role
hcv
replic
infecti
viru
support
find
also
report
essenti
hcv
rna
replic
presum
reloc
ld
interact
result
garaigorta
et
demonstr
hcv
hijack
pkr
phosphorylationtrigg
sg
format
downregul
translat
antivir
isg
therebi
promot
viral
rna
replic
viru
assembl
egress
upon
sens
activ
pamp
viral
dsrna
certain
ifnstimul
protein
synthes
atp
bind
short
oligoadenyl
ubiquit
latent
endonucleas
rnase
l
activ
dimer
degrad
either
cellular
viral
rna
result
inhibit
protein
synthesi
cellular
apoptosi
impair
viru
therefor
oasrnas
l
pathway
repres
critic
arm
ifn
antivir
effector
mechan
mani
virus
includ
depend
specif
rna
substrat
extent
enzymat
activ
rnase
l
block
differ
type
virus
differ
mechan
apoptosi
suppressor
viru
rna
deriv
cellular
viral
nevertheless
member
oa
famili
exert
antivir
activ
independ
rnase
oa
system
report
exert
antihcv
effect
rnase
l
pathway
ua
uu
dinucleotid
within
loop
predict
stemloop
structur
viral
rna
prone
cleavag
rnase
l
tabl
addit
sensit
hcv
infect
ifn
therapi
correl
effici
rnase
lmediat
viral
rna
antihcv
activ
oa
famili
occur
rnase
ldepend
fashion
tabl
hcv
replic
suppress
hcvccinfect
cell
cocultur
hepat
stellat
cell
treat
incub
condit
medium
cell
stimul
hcvccinfect
cell
express
mxa
two
differ
domain
oaslik
oasla
major
isoform
human
liver
induc
hcv
contribut
antivir
activ
ntermin
oa
homolog
domain
lack
cleavag
activ
impair
cell
prolifer
well
viral
replic
wherea
ctermin
ublik
domain
imped
hcv
replic
without
affect
cell
growth
tabl
ifnstimul
gene
kda
protein
emerg
second
ifnregul
rnase
inhibit
rna
viru
along
close
relat
belong
yeast
rna
exonucleas
homolog
subfamili
within
deddh
exonucleas
famili
member
superfamili
possess
rnase
dnase
exonucleas
activ
demonstr
greater
prefer
singlestrand
rna
singlestrand
overexpress
restrict
infect
encephalomyocard
viru
vsv
influenza
viru
infv
human
immunodefici
viru
hiv
yfv
picornaviru
report
impair
hcv
genotyp
sgr
replic
cell
tabl
addit
hinder
genotyp
viral
rna
replic
either
sgr
hcvcc
infect
antihcv
effect
share
tabl
apart
degrad
viral
rna
exonucleas
antihcv
mechan
hcv
replic
remain
poorli
understood
despit
possibl
action
cellular
rnaspecif
adenosin
deaminas
adar
constitut
express
normal
cell
inact
howev
viral
infect
trigger
two
mammalian
adar
gene
express
two
activ
protein
adar
catalyz
adenosin
inosin
edit
rna
possess
doublestrand
recogn
guanosin
rna
polymeras
edit
caus
nucleotid
substitut
well
dsrna
destabil
reduc
stabil
u
mismatch
base
pair
compar
normal
base
rna
edit
abil
adar
affect
mani
biolog
process
includ
viral
replic
persist
apoptosi
ion
channel
function
posttranscript
modif
transcript
level
induc
ifn
treatment
pathogen
addit
affect
stabil
hcv
replicon
rna
tabl
hcv
sgr
replic
treatment
decreas
viral
rna
replic
concomitantli
increas
express
suggest
possess
antivir
activ
hcv
rna
knockdown
convers
increas
hcv
replicon
loss
hcv
rna
may
due
sever
first
basespecif
rnase
might
target
mutat
viral
rna
second
mutat
rna
might
lead
insuffici
replic
genom
third
cellular
mrna
involv
viral
replic
may
also
target
thu
rna
edit
abil
neg
affect
hcv
rna
replic
repres
potent
strategi
antihcv
therapi
sharp
contrast
replic
hepat
delta
viru
hdv
benefit
edit
hdv
rna
convert
uag
stop
codon
uig
tryptophan
codon
allow
synthesi
larger
hdv
without
viral
rna
edit
hdv
genom
packag
nonetheless
adar
overexpress
increas
rna
edit
decreas
hdv
ifitm
famili
member
includ
inhibit
ifitmspecif
manner
replic
divers
pathogen
membraneenvelop
virus
includ
marburg
viru
ebola
ebov
filovirus
sever
acut
respiratori
coronaviru
hiv
rift
valley
fever
viru
rvfv
respiratori
syncyti
viru
reoviru
flavivirus
includ
denv
wnv
contrast
ifitm
show
inhibitori
effect
entri
amphotrop
mous
leukemia
viru
machupo
viru
lassa
viru
lymphocyt
choriomening
ifitm
topolog
locat
differ
intracellular
membran
compart
type
ii
transmembran
protein
primarili
local
endosom
wherea
also
local
cell
interact
ifitm
member
enhanc
ifn
lipid
raft
membran
enrich
cholesterol
sphingolipid
play
vital
role
cellular
pathway
viru
entri
assembl
vesicleassoci
membran
proteinassoci
protein
vapa
oxysterolbind
protein
osbp
modul
intracellular
traffick
de
novo
synthesi
vapa
interact
osbp
regul
transfer
cholesterol
er
regul
intracellular
cholesterol
homeostasi
particularli
endosom
compart
critic
entri
virus
ebov
marburg
ifitm
demonstr
interfer
viru
infect
block
virusendosom
fusion
tabl
presum
modif
cellular
membran
properti
fluiditi
spontan
aminibavilolyae
et
demonstr
interact
vapa
antagon
associ
vapa
osbp
therebi
induc
accumul
cholesterol
multivesicular
bodi
late
endosom
disrupt
intracellular
cholesterol
homeostasi
subsequ
impair
membran
fusion
intralumin
virioncontain
vesicl
endosom
result
block
vsv
releas
use
immort
human
hepatocyt
infect
model
raychoudhuri
demonstr
express
inhibit
hcv
replic
viru
later
wilkin
et
identifi
hepatocyt
tight
junction
protein
whose
antivir
action
occur
modif
interact
hcv
coreceptor
occludin
therebi
inhibit
hcv
entri
tabl
studi
repres
interest
mode
antivir
innat
immun
isg
exert
antihcv
action
disrupt
viral
coreceptor
associ
ifninduc
protein
tetratricopeptid
repeat
ifit
famili
repres
class
isg
featur
uniqu
motif
known
tetratricopeptid
repeat
ifit
mediat
broad
rang
interact
particular
tetratricopeptid
repeat
motif
critic
modul
protein
translat
initi
transport
cell
prolifer
migrat
viru
replic
antivir
protein
ifit
famili
link
ifn
antivir
function
includ
wnv
lymphocyt
choriomening
play
import
role
modul
innat
immun
bridg
mav
mitochondria
express
facilit
associ
tetratricopeptid
repeat
motif
n
terminu
therebi
enhanc
gene
also
known
belong
famili
also
contain
stressinduc
structur
relat
protein
human
act
negativefeedback
regul
sendai
virustrigg
induct
type
ifn
antivir
signal
transduct
presum
interact
adapt
protein
sting
disrupt
normal
associ
stingmita
mav
moreov
preferenti
target
mutant
poxviru
coronaviru
wnv
lack
methyl
viral
rna
cap
therebi
render
mutant
virus
unabl
studi
address
mechan
methyl
cap
viral
rna
render
virus
insensit
ifitmedi
host
innat
antivir
activ
wang
et
demonstr
mediat
ifn
antivir
activ
block
hcv
rna
replic
presum
target
step
viral
iresmedi
translat
tabl
immort
human
hepatocyt
infect
model
raychoudhuri
document
express
inhibit
hcv
replic
suppress
hcv
iresmedi
convers
knockdown
facilit
hcv
result
suggest
restrict
hcv
infect
primarili
viral
translationrepl
site
protein
posttransl
modif
ub
ubl
modifi
play
import
role
numer
cellular
process
protein
local
interact
activ
degrad
signal
transduct
vesicular
traffick
dna
damag
also
modul
interact
viral
replic
cycl
host
antivir
first
ubl
protein
modifi
posttransl
attach
via
c
terminu
lysin
residu
isg
hundr
target
protein
involv
differ
similar
ub
homolog
link
protein
via
tightli
regul
process
known
isgyl
activ
conjug
ligat
enzym
catalyz
sequenti
togeth
conjug
ligas
deconjug
enzym
ubl
pathway
isgyl
modul
signal
transduct
pathway
host
antivir
respons
exert
modulatori
role
inhibit
viru
releas
isoyl
viral
protein
modifi
host
target
mani
cellular
protein
includ
mani
isg
three
antivir
effector
molecul
rigi
pkr
also
modifi
activ
stabil
isgyl
therefor
posit
regul
type
ifn
conjugationmedi
reduct
nonisgyl
rigi
correl
reduc
ndvtrigger
ifn
addit
viral
rnaindepend
pkr
activ
requir
isgyl
express
enhanc
ifnmedi
antivir
activ
mani
virus
includ
hiv
overexpress
receptor
knockout
mice
decreas
sinv
replic
protect
mice
sinvinduc
mice
suscept
infect
mani
rna
dna
virus
infv
herp
simplex
viru
hsv
type
protect
effect
sinv
infect
depend
lu
et
demonstr
induct
express
ndvinfect
cell
counteract
ubmedi
degrad
enhanc
ndvmediat
host
innat
antivir
respons
find
reveal
feedback
mechan
enhanc
antivir
immun
despit
function
antivir
molecul
isgyl
antivir
rigi
enzym
inhibit
ifn
signal
mous
embryon
fibroblast
use
genotyp
fulmin
chimer
hcv
infecti
model
chen
et
unexpectedli
found
act
prohcv
regul
increas
facilit
hcv
product
wherea
block
isgyl
decreas
viru
product
tabl
moreov
knockdown
activ
enzym
inhibit
hcv
replic
particularli
hcv
egress
without
affect
ifnmedi
isg
express
hcvinfect
use
infect
system
arnaud
et
al
dissect
acut
ifn
respons
hcv
infect
earli
pkr
late
rigi
hcv
infect
rapidli
induc
express
mani
gene
includ
pkrdepend
mechan
rigi
phase
recruit
induct
block
hcv
rnamedi
rigi
activ
inhibit
rigi
ubiquitin
therebi
neg
control
rigimav
studi
illustr
hcv
may
exploit
antagon
host
innat
immun
promot
viral
replic
deconjug
target
protein
catalyz
mous
ortholog
function
mode
shown
bind
attenu
jakstat
pathway
therebi
neg
regul
ifn
signal
tabl
reduc
express
result
increas
antivir
activ
mani
virus
sinv
hepat
b
viru
vsv
knockout
knockdown
concomit
increas
cellular
protein
isgyl
prolong
tyrosin
phosphoryl
enhanc
isg
express
thu
greatli
enhanc
antihcv
potenc
studi
suggest
disrupt
imped
neg
regulatori
effect
ifn
signal
result
sustain
activ
antivir
activ
consist
observ
murray
et
demonstr
signal
isg
induct
greatli
increas
knock
hcv
sgr
hcvccinfect
cell
howev
knockdown
signific
effect
antihcv
observ
suggest
slight
depend
ifnmedi
antivir
activ
addit
upregul
predict
nonsustain
viral
respons
ifn
express
level
increas
liver
biopsi
specimen
chronic
hcvinfect
patient
respond
ifnbas
therapi
infer
hcv
hijack
pathway
evad
antivir
immun
respons
facilit
replic
tabl
observ
also
explain
least
partial
failur
ifnbas
treatment
nonrespond
although
nonrespond
express
higher
level
isg
particularli
compar
ifn
taken
togeth
find
demonstr
attract
target
develop
antihcv
therapeut
viperin
stand
viru
inhibitori
protein
endoplasm
reticulumassoci
ifninduc
play
crucial
role
viru
replic
signal
immun
viperin
protein
sequenc
highli
conserv
viperin
homolog
contain
three
function
domain
amphipath
ntermin
domain
mediat
er
ld
associ
central
cxxxcxxc
motif
function
import
cluster
format
highli
conserv
ctermin
domain
essenti
antivir
addit
type
type
ii
type
iii
ifn
dsdna
dsrna
analog
bacteria
lipopolysaccharid
poli
c
broad
spectrum
dna
rna
virus
induc
viperin
viperin
express
regul
mani
cellular
function
form
ld
reduc
membran
viperin
possess
antivir
activ
divers
famili
dna
rna
virus
includ
infv
hiv
sinv
flavivirus
japanes
enceph
viru
denv
wnv
hepaciviru
hcv
tabl
viperin
function
differ
way
defend
viru
infect
instanc
viperin
alter
membran
fluiditi
interact
farnesyl
diphosph
synthas
enzym
essenti
isoprenoid
biosynthesi
thu
disrupt
format
lipid
raft
site
infv
bud
lead
interfer
viru
releas
cell
induct
viperin
cell
disrupt
lipid
raft
caus
viperin
redistribut
compart
bud
human
radic
sadenosylmethionin
enzymat
activ
viperin
requir
inhibit
hiv
cell
infect
japanes
enceph
viru
antivir
function
viperin
attenu
due
degrad
proteasomemedi
protein
degrad
contrast
viperin
enhanc
human
cytomegaloviru
infect
interact
viral
mitochondri
inhibitor
apoptosi
vmia
protein
result
viperin
reloc
er
mitochondria
viperin
interact
mitochondri
trifunct
protein
reduc
cellular
atp
gener
result
disrupt
actin
cytoskeleton
enhanc
viru
viperin
upregul
cell
transfect
either
poli
c
hcv
transient
express
viperin
hcv
sgr
replic
cell
significantli
decreas
hcv
put
radic
sadenosylmethionin
enzymat
activ
viperin
requir
antihcv
helbig
et
demonstr
restrict
hcvcc
replic
viperin
depend
ntermin
amphipath
ctermin
domain
antihcv
function
viperin
coincid
bind
ld
interfac
wherea
normal
associ
human
homolog
vesicleassoci
membran
proteinassoci
protein
provir
cellular
factor
viral
replic
interact
hcv
previous
shown
critic
format
viral
replic
therefor
associ
viperin
requir
ctermin
domain
disturb
interact
inhibit
hcv
replic
tabl
togeth
find
impli
viperin
hinder
viral
rna
replic
perturb
interact
conduct
bioinformat
analys
murin
bone
marrowderiv
macrophag
liu
et
al
show
isg
mitig
replic
mani
membraneenvelop
virus
includ
hiv
vsv
hsv
murin
mani
pathogen
virus
rvfv
ebov
russian
springsumm
enceph
viru
nipah
viru
vitro
virus
contain
differ
structur
characterist
fusion
protein
instanc
hiv
ebov
contain
class
fusion
peptid
rvfv
russian
springsumm
enceph
viru
harbor
class
ii
peptid
vsv
hsv
belong
class
iii
fusion
broadli
antivir
action
gene
product
mediat
abil
enzymat
product
inhibit
phdepend
phindepend
membran
fusion
cell
virus
typifi
vsv
hiv
respect
tabl
studi
demonstr
ifn
confer
antivir
state
host
andor
target
cell
induc
natur
oxysterol
inhibitor
also
suggest
modif
membran
oxysterol
use
potenti
antivir
determin
whether
broad
antivir
isg
block
hcvmediat
membran
fusion
would
interest
sever
genomewid
sirna
screen
recent
perform
identifi
isg
ifnmedi
effector
gene
ieg
mediat
ifn
antivir
function
studi
identifi
mani
new
isg
ieg
reveal
interest
featur
action
isg
use
overexpress
screen
approach
schoggin
et
demonstr
viru
exhibit
uniqu
partial
overlap
profil
antivir
isg
express
express
level
isg
may
vari
depend
viral
infect
time
dose
cell
type
use
ifn
hcv
infect
higher
express
level
uniqu
isg
found
correl
reduct
hcv
viral
schoggin
et
observ
multipl
isg
gene
could
target
viral
speci
rang
inhibitori
activ
set
effector
includ
also
known
heparanas
rigi
exert
broad
antivir
activ
differ
virus
includ
hcv
yfv
wnv
chikungunya
viru
venezuelan
equin
enceph
viru
howev
effector
ifninduc
protein
mapk
kinasekinas
moloney
leukemia
viru
nicotinamidephosphoribosyltransferas
oasl
receptor
transport
protein
three
prime
repair
exonucleas
protein
homolog
b
display
speciesspecif
antivir
effector
result
also
demonstr
differ
isg
exert
addit
antivir
effect
viru
remark
sever
isg
adar
famili
sequenc
similar
member
c
lymphocyt
antigen
enhanc
replic
certain
certainli
character
isg
antagon
ifnmedi
antivir
function
determin
step
viru
replic
target
isg
import
find
indic
complex
type
ifnmedi
innat
immun
respons
viru
replic
perform
sirnabas
gain
function
screen
metz
et
identifi
sever
new
antihcv
isg
addit
previous
report
antihcv
isg
studi
demonstr
upregul
express
sever
isg
includ
phospholipid
scramblas
induc
nitric
oxid
synthas
isg
possess
antihcv
activ
although
precis
role
isg
hcv
replic
studi
also
report
substanti
overlap
antivir
innat
immun
respons
trigger
either
howev
isg
specif
induc
instanc
phospholipid
scramblas
nitric
oxid
synthas
primarili
function
antihcv
moreov
differ
isg
function
addit
synergist
interfer
hcv
indic
combinatori
concert
action
multipl
effector
mediat
repress
hcv
replic
addit
signal
molecul
involv
major
gene
identifi
fusco
et
al
transcript
activ
contrast
notion
isg
target
specif
viru
replic
step
gene
exert
ifnmedi
antivir
effect
multipl
step
hcv
replic
instanc
dipeptidylpeptidas
deaminas
complex
protein
block
viru
entri
initi
rna
replic
amplifi
translat
histon
acetyltransferas
inhibit
hcv
entri
translat
rna
replic
virion
releas
protein
phosphatas
catalyt
subunit
isoform
impair
viru
entri
initi
rna
replic
subsequ
translat
taken
togeth
find
reveal
ifninsensit
ieg
togeth
isg
constitut
host
cellular
gene
mediat
antivir
activ
ifn
viral
replic
function
genom
screen
shown
sever
new
gene
compris
trismal
nuclear
ribonucleoprotein
snrnp
possess
abil
mediat
ifn
antivir
trisnrnp
major
compon
human
spliceosom
complex
involv
mrna
genom
screen
demonstr
squamou
cell
carcinoma
antigen
recogn
cell
trisnrnpspecif
factor
requir
antihcv
activ
although
induc
antihcv
activ
act
regul
express
isg
mxa
oa
pkr
either
presenc
absenc
exogen
genet
screen
link
unappreci
role
rna
process
control
antivir
immun
hcv
coopt
intrins
innat
pathway
hijack
cellular
lipid
metabol
facilit
assembl
initi
identifi
critic
factor
hcv
replic
genomewid
rna
interfer
subsequ
hcv
infect
shown
activ
interact
viral
genom
dead
box
polypeptid
xlink
transloc
nucleu
induc
express
lipogen
gene
includ
sterol
regulatori
elementbind
protein
follow
promot
coremedi
ld
format
enhanc
hcv
assembl
tabl
dansako
demonstr
upon
hcv
express
class
scaveng
receptor
type
express
plasma
membran
infect
adjac
uninfect
cell
bind
dsrna
releas
infect
cell
mediat
endocytosi
transport
endosom
dsrna
sens
initi
local
antivir
ifn
respons
restrict
hcv
bind
transport
releas
dsrna
acidifi
endosom
requir
stretch
conserv
basic
residu
within
c
terminu
collagen
superfamili
domain
therefor
act
key
element
prr
therebi
render
infect
uninfect
hepatocyt
refractori
hcv
replic
tabl
abund
nuclear
protein
mediat
activ
host
immun
respons
inflamm
repres
prototyp
damageassoci
molecular
pattern
particip
pathogenesi
divers
passiv
releas
cell
injuri
ischemia
without
pathogen
invas
activ
secret
stimul
immun
cell
natur
killer
cell
macrophag
matur
dendrit
mani
type
tlr
act
receptor
product
reactiv
oxygen
speci
mediat
transloc
nucleu
cytoplasm
subsequ
releas
interestingli
shown
hcv
core
trigger
oxid
stress
infect
jung
et
demonstr
hcv
infect
caus
nucleartocytoplasm
transloc
releas
extracellular
milieu
act
major
compon
receptor
complex
recogn
lipopolysaccharid
lp
play
role
product
proinflammatori
cytokin
antivir
ifn
via
signal
tlr
adapt
protein
jung
et
also
demonstr
interact
activ
ifn
signal
tabl
present
higher
level
sera
patient
chronic
hepat
cirrhosi
compar
detect
control
result
jung
et
al
may
help
elucid
potenti
inhibitori
action
hcv
propag
chronic
hcvinfect
autophagi
conserv
selfeat
process
engulf
deliv
cytoplasm
cargo
invad
pathogen
within
doubl
multiplemembran
autophagosom
structur
lysosom
purpos
autophag
induct
maintain
cellular
homeostasi
host
host
undergo
extracellular
intracellular
stress
autophagi
play
pivot
role
stress
respons
nutrient
depriv
damag
organel
unfold
protein
aggreg
intracellular
qualiti
control
cell
autophag
process
requir
two
ubl
conjug
complex
autophagyrel
gene
atg
microtubuleassoci
protein
light
chain
autophagi
emerg
immun
regul
command
innat
adapt
immun
respons
intracellular
autophagi
also
particip
modul
interact
contrast
virus
subvert
host
autophag
pathway
potenti
analog
hcv
abl
subvert
host
autophag
machineri
enhanc
viral
growth
includ
rna
translat
incom
viral
rna
releas
infecti
virus
tabl
two
laboratori
independ
demonstr
hcv
activ
autophagi
via
er
stressmedi
induct
upr
uprautophagi
requir
hcv
hcv
also
implic
induct
huang
et
show
hcv
induc
er
stress
inhibit
complex
signal
pathway
result
autophagi
activ
contrast
shrivastava
et
demonstr
hcv
induc
autophagi
stimul
beclin
mrna
express
activ
mtor
signal
may
enhanc
hepatocyt
growth
ke
demonstr
context
hcv
infect
without
hcv
infect
activ
upr
autophagi
downregul
innat
immun
contrast
disrupt
upr
autophagi
upregul
innat
immun
result
demonstr
hcv
hijack
upr
autophagi
stimul
viral
rna
replic
suppress
immun
antivir
immun
pathway
repres
uniqu
mode
revers
control
innat
immun
capac
target
subsequ
shrivastava
et
found
beclin
gene
silenc
genotyp
strain
hcvinfect
immort
human
hepatocyt
upregul
ifn
signal
isg
express
concurr
apoptot
cell
death
togeth
result
two
group
suggest
autophagi
may
protect
hcvinfect
cell
damag
caus
excess
ifn
antivir
stimul
therebi
promot
hcv
rna
replic
furthermor
specif
mode
autophagi
term
mitophagi
recent
report
play
critic
role
hcv
replic
elimin
damag
mitochondria
infect
cell
parkindepend
knockdown
parkin
pink
gene
express
suppress
viral
rna
replic
tabl
result
suggest
critic
role
mitophagi
hcv
replic
nevertheless
molecular
basi
role
autophagi
mitophagi
suppress
innat
antivir
immun
hcv
infect
yet
investig
recent
studi
demonstr
mani
differ
famili
rna
virus
target
autophagi
network
promot
viral
among
target
irgm
modul
autophagi
interact
mani
autophagyassoci
protein
light
chain
strikingli
irgm
knockdown
impair
autophagi
induc
mani
virus
hcv
mev
result
mitig
viral
replic
tabl
c
protein
mev
hcv
nef
shown
induc
autophagi
interact
irgm
result
suggest
rna
virus
evolv
use
common
strategi
target
critic
molecul
autophagi
benefit
growth
microrna
class
endogen
small
noncod
rna
bind
target
mrna
control
gene
microrna
also
particip
innat
adapt
immun
respons
bind
complementarili
mrna
regul
express
translat
target
exampl
regul
host
antivir
immun
respons
promot
type
ifn
wherea
enhanc
mrna
shown
upregul
liver
sampl
hepatocellular
carcinoma
patient
hcvinfect
hcv
infect
express
activ
pkcejnkcjun
cjun
cfo
form
protein
bind
promot
activ
upregul
shown
suppress
express
two
gene
involv
tlr
signal
cascad
therebi
repress
product
type
ifn
isg
promot
hcv
replic
tabl
result
indic
hcv
usurp
enhanc
replic
likewis
also
increas
product
hiv
vsv
enteroviru
suppress
type
ifn
mechan
virus
cell
coevolv
tactic
parti
employ
establish
dynam
equilibrium
emerg
fascin
area
interact
research
previou
studi
aim
understand
hcv
cell
coevolut
process
reveal
sever
interest
aspect
virushost
cell
interact
er
stress
upr
autophagi
innat
antivir
immun
respons
hcv
determin
viruscel
interplay
subsequ
reshap
host
defens
mechan
viru
replic
modul
respons
cellular
stress
import
gain
complet
understand
molecular
basi
interact
pathogenesi
hcv
infect
viral
infect
trigger
ifnmedi
frontlin
host
defens
mechan
includ
product
wide
rang
isg
limit
viru
replic
mani
studi
also
hitherto
demonstr
identifi
isg
exert
broad
antivir
activ
divers
spectrum
virus
wherea
isg
may
viru
typespecif
function
major
studi
isg
mediat
ifn
antivir
activ
act
neg
regul
viru
replic
strikingli
isg
function
neg
modifi
innat
immun
respons
therebi
promot
viru
replic
nevertheless
mode
action
isg
remain
unclear
although
identifi
isg
target
individu
step
viru
replic
isg
seem
act
multipl
stage
viru
replic
cycl
determin
mechan
isg
function
differ
step
viru
replic
cycl
would
interest
current
studi
indic
differ
type
ifn
may
substanti
overlap
mediat
innat
immun
respons
activ
set
isg
howev
induct
isg
may
uniqu
one
type
ifn
indic
specif
induct
isg
ifn
clearli
differ
isg
addit
synergist
suppress
hcv
replic
suggest
inhibit
hcv
replic
depend
combinatori
effect
individu
isg
induc
ifn
specif
context
hcv
infect
therefor
ifnmedi
suppress
hcv
replic
caus
singl
isg
rather
concert
action
multipl
isg
moreov
gene
express
profil
hepatocyt
chronic
hcvinfect
patient
treat
ifn
consist
shown
differ
ifnrespond
ifnnonrespond
instanc
level
specif
isg
viral
sensor
rigi
laboratori
genet
upregul
patient
nonsustain
virolog
respons
compar
patient
sustain
virolog
therefor
profil
gene
express
cytoplasm
viral
sensor
relat
regul
involv
innat
antivir
immun
respons
identifi
new
isg
use
marker
predict
clinic
outcom
ifn
therapi
conclus
emerg
complex
highli
pleiotrop
type
ifn
system
hcv
infect
reveal
host
evolv
erect
multipl
checkpoint
antihcv
innat
immun
surveil
ensur
hcv
tight
control
time
even
singl
effector
fail
confer
antivir
activ
without
drastic
downgrad
overal
efficaci
ifn
treatment
therefor
deciph
isg
andor
ieg
induc
ifn
upon
hcv
infect
specif
action
isg
cellular
immun
regul
hcv
replic
provid
insight
ifn
function
obstruct
hcv
replic
also
reveal
novel
cellular
target
effect
efficaci
antihcv
therapeut
develop
